INmune Bio - 48 Year Dividend History | INMB

Historical dividend payout and yield for INmune Bio (INMB) since 1971. The current TTM dividend payout for INmune Bio (INMB) as of December 11, 2019 is $0.00. The current dividend yield for INmune Bio as of December 11, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.053B $0.000B
INmune Bio Inc. is a clinical-stage biotechnology company. It engages in developing therapies targeting the innate immune system in cancer. The company's product platform consists of INKmune and INB03. INKmune is a natural killer cell therapeutic which primes the patient's NK cells to attack developing disease. INB03 inhibits myeloid derived suppressor cells which often cause resistance to immunotherapy, such as anti-PD1 checkpoint inhibitors. INmune Bio Inc. is based in La Jolla, United States.
Stock Name Country Market Cap PE Ratio